News | Wearable Sensors | October 13, 2016

Biotricity Expands Partnership with the University of Calgary on Wearable Monitors

Partnership will continue to develop the next generation of medically relevant wearable monitors; Biotricity expects FDA response to 510(k) submission shortly

October 13, 2016 — Biotricity Inc. announced recently that it will be expanding its existing research partnership with the University of Calgary. In order to develop and validate the next generation of medically relevant wearable monitors, the focus of the new partnership will be on areas beyond cardiac medicine, including fetal monitoring and sleep apnea.

Biotricity’s goal is to develop a series of clinically accurate devices that are applicable in both clinical and home-based settings. The initial focus of this expanded partnership will be to investigate using heart rate variability monitoring (HRVM) to optimize recovery after surgery and medical illness, and to develop solutions for the fetal monitoring and sleep apnea markets as well.

David Liepert, Ph.D., a clinical assistant professor at the University of Calgary Cumming School of Medicine, anesthesiologist at AHS’ Rockyview General Hospital and lead investigator of the study added, “The Department of Anesthesia and Peri-Operative Medicine looks forward to expanding on the developmental heart rate variability monitoring  work we have already completed with the Bioflux device, and working with Biotricity's consumer-based Biolife device as well.”

He explained, “HRVM’s ability to simultaneously monitor internal physiology and activities of daily living combined with Biotricity’s convenience and portability seems ideal for tracking return-to-function and allowing early and individualized intervention and optimization. Maternal/fetal monitoring has long-included HRVM, and exploring the impact of offering convenience and portability to that patient group as well as the sleep apnea population is an exciting opportunity. We look forward to capitalizing on [Biotricity CEO and founder] Waqaas Al-Siddiq's expertise in wearable biometric monitoring, connectivity and data processing and are also exploring the benefits of creating a relationship with the University of Calgary's Schulich School of Engineering which would be of utmost value to Alberta's budding Biomedical Engineers."

In other news, Biotricity is expecting a response from the U.S. Food and Drug Administration (FDA) to their 510(k) submission within the next few weeks.

For more information: www.biotricity.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC| September 07, 2017
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Advances in FFR, FFR-CT, was the most popular cardiology story in August 2017.

The most popular article in August was about advances in fractional flow reserve (FFR) technologies. The image shows Philips' new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions.

Feature | September 01, 2017 | Dave Fornell
September 1, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Car
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Overlay Init